NCT03760718View on ClinicalTrials.gov

Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

September 17, 2020

Study Completion Date

December 31, 2021

Conditions
Cesarean Section
Interventions
DRUG

Preservative free 1% Chloroprocaine

40 ml of preservative-free 1% chloroprocaine is planned for administration into the peritoneal cavity after delivery of the baby.

DRUG

Preservative free 2% Chloroprocaine

40 ml of preservative-free 2% chloroprocaine is planned for administration into the peritoneal cavity after delivery of the baby.

DRUG

Preservative free 3% Chloroprocaine

40 ml of preservative-free 3% chloroprocaine is planned for administration into the peritoneal cavity after delivery of the baby.

Trial Locations (1)

97239

OHSU Labor and Delivery; Oregon Health and Science University Hospital, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT03760718 - Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery | Biotech Hunter | Biotech Hunter